According to a TechCrunch report, OpenAI researcher Miles Wang intends to depart from the company to establish a startup focused on AI-driven drug discovery. Sources indicate that Wang is currently negotiating a funding round of approximately $200 million, which would value the new venture at $2 billion, with Lightspeed expected to head the investment. The company plans to develop artificial intelligence models designed to identify novel applications for drugs that are already in existence.

by shortkt.com✓

5 घंटे पहले